The global high flow nasal cannula Industry has witnessed substantial growth in recent years, driven by a combination of technological advancements, increased prevalence of respiratory disorders, and ...

As the COVID-19 pandemic continues, increasing the number of patients suffering from respiratory conditions and requiring respiratory support, softFlow offers clinicians across the continuum of care ...

Respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) are frequent complications of prematurity. To decrease ventilator-induced lung injury, we evaluated the safety, efficacy and ...

NEWARK, Del, March 05, 2024 (GLOBE NEWSWIRE) -- The high flow nasal cannula market is poised to undergo a reduction, projected to diminish from US$ 1,369.3 Million in 2024 to US$ 1,063.0 Million by ...

To compare the feasibility of continuous positive airway pressure (CPAP) support generated by high flow nasal cannula with conventional CPAP for prevention of reintubation among preterm infants with a ...

Sales of global high flow nasal cannula Industry size are anticipated to increase between 2022 and 2030 at a CAGR of 11.6%. By 2030, the market for high flow nasal cannulas is expected to be valued ...

New York, NY, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “High-Flow Nasal Cannula Market By End-User (Long-Term Care Centers, Hospitals, ...

Please provide your email address to receive an email when new articles are posted on . Treating bronchiolitis outside the ICU with weight-based high-flow nasal cannula protocols reduced ICU ...

Compared to ventilator care, nasal high flow therapy for seriously ill coronavirus patients has several benefits, including the ability to mobilize patients. Nasal high flow (NHF) therapy is a less ...

The complexity of the disease has made ventilator use challenging. Treatment of COVID-19 has been a medical puzzle for front-line doctors largely learning about the disease in real-time without proven ...